Cross-fund · 4 holders
ATNM
ACTINIUM PHARMACEUTICALS INC
CUSIP 00507W206
4
Tracked holders
$3.0M
Aggregate value
2,457,948
Shares
5
Active funds
Funds holding ATNM
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $1.9M | — | +36,495 | +2.6% |
| Millennium | Multi-Strategy | Q1 2026 | $561,946 | — | −37,000 | −6.2% |
| BlackRock | Institutional | Q1 2026 | $369,466 | — | +4,279 | +1.2% |
| Citadel | Multi-Strategy | Q1 2026 | $100,625 | — | −13,600 | −11.9% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | −10,295 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.